SIG
XBI icon

Stanford Investment Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Stanford Investment Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,205
Closed -$155K – 371
2015
Q4 		$155K Buy
2,205
+600
+37% +$40.9K 0.08% 67
2015
Q3 		$100K Buy
+1,605
New +$126K 0.07% 80

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Stanford Investment Group's XBI Position: Q1 2016 in Review

Stanford Investment Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2016, closing a stake of 2,205 shares — an estimated $155K sold.

Stanford Investment Group first reported a position in XBI in Q3 2015 and held it in 2 quarters. The position peaked at $155K in Q4 2015. 195 funds tracked by Wall St. Rank hold XBI as of Q1 2016.

  • Stanford Investment Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2016 after selling out during the quarter.
  • Stanford Investment Group sold 2,205 State Street SPDR S&P Biotech ETF shares in Q1 2016, an estimated $155K.
  • Stanford Investment Group first reported a position in State Street SPDR S&P Biotech ETF in Q3 2015 and held it in 2 quarters.
  • Stanford Investment Group's State Street SPDR S&P Biotech ETF position peaked at $155K in Q4 2015.
  • 195 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2016.

Based on Stanford Investment Group's 13F filing for Q1 2016, filed 10 Nov 2016.